These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 6835557)

  • 21. [Fosfomycin in urogenital infections. Experimental assumptions and clinical results].
    Savoia D; Fontana G; Laudi M; Cauda F
    Minerva Med; 1978 Dec; 69(59):4087-91. PubMed ID: 740304
    [No Abstract]   [Full Text] [Related]  

  • 22. Fosfomycin: use beyond urinary tract and gastrointestinal infections.
    Falagas ME; Giannopoulou KP; Kokolakis GN; Rafailidis PI
    Clin Infect Dis; 2008 Apr; 46(7):1069-77. PubMed ID: 18444827
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical evaluation of fosfomycin in dental infectious pathology].
    Cofini S; Agopovich G; Arcuri C
    Clin Ter; 1984 Dec; 111(6):539-43. PubMed ID: 6525813
    [No Abstract]   [Full Text] [Related]  

  • 24. [Tolerance to fosfomycin using greatly elevated doses in the treatment of urinary septicemia in renal insufficiency].
    Neuman M
    Minerva Med; 1978 Dec; 69(59):4105-6. PubMed ID: 740306
    [No Abstract]   [Full Text] [Related]  

  • 25. Fosfomycin for urinary tract infections.
    Med Lett Drugs Ther; 1997 Jul; 39(1005):66-8. PubMed ID: 9255237
    [No Abstract]   [Full Text] [Related]  

  • 26. [Fosfomycin].
    Gobernado M
    Rev Esp Quimioter; 2003 Mar; 16(1):15-40. PubMed ID: 12750755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Coexpression of virulence and fosfomycin susceptibility in Listeria: molecular basis of an antimicrobial in vitro-in vivo paradox.
    Scortti M; Lacharme-Lora L; Wagner M; Chico-Calero I; Losito P; Vázquez-Boland JA
    Nat Med; 2006 May; 12(5):515-7. PubMed ID: 16633349
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fosfomycin for Pseudomonas-related exacerbations of cystic fibrosis.
    Faruqi S; McCreanor J; Moon T; Meigh R; Morice AH
    Int J Antimicrob Agents; 2008 Nov; 32(5):461-3. PubMed ID: 18703318
    [No Abstract]   [Full Text] [Related]  

  • 29. In vivo interaction of cis-platinum and fosfomycin on squamous cell carcinoma.
    Tandy JR; Tandy RD; Farris P; Truelson JM
    Laryngoscope; 2000 Jul; 110(7):1222-4. PubMed ID: 10892700
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Phosphomycin for the prevention of bacterial infections in high risk patients].
    Faedda R; Tocco A; Vacca R; Deplano A; Olmeo NA; Branca FG; Bartoli E
    Clin Ter; 1981 Nov; 99(3):295-304. PubMed ID: 7307457
    [No Abstract]   [Full Text] [Related]  

  • 31. [Improvement of the therapeutic efficacy of fosfomycin by addition of glucose-6-phosphate in the treatment of intraperitoneally infected mice (author's transl)].
    Hirschl A; Stanek G; Rotter M
    Zentralbl Bakteriol A; 1980; 246(4):562-6. PubMed ID: 6999793
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful treatment of disseminated methicillin-resistant Staphylococcus aureus with fosfomycin, cefoperazone/sulbactam and rifampin followed by fusidic acid and rifampin.
    Apisarnthanarak A; Mundy LM
    Int J Infect Dis; 2007 May; 11(3):283-4. PubMed ID: 16876452
    [No Abstract]   [Full Text] [Related]  

  • 33. [Prerequisites for enhancement of the efficacy of fosfomycin by glucose-6-phosphate in treatment of experimentally infected animals (author's transl)].
    Hirschl A; Stanek G; Rotter M; Holzmann A; Frisch-Niggemeyer W; Laber G
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981 Nov; 250(4):529-39. PubMed ID: 7036592
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Colorimetric determination of fosfomycin in biological fluids].
    Csiba A
    Acta Pharm Hung; 1980 Jan; 50(1):12-20. PubMed ID: 7361552
    [No Abstract]   [Full Text] [Related]  

  • 35. Other antimicrobials of interest in the era of extended-spectrum beta-lactamases: fosfomycin, nitrofurantoin and tigecycline.
    Garau J
    Clin Microbiol Infect; 2008 Jan; 14 Suppl 1():198-202. PubMed ID: 18154548
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Preliminary data on the utilization of monural to treat pregnant women with asymptomatic bacteriuria].
    Ivanov S; Michova M; Batashki I
    Akush Ginekol (Sofiia); 2008; 47 Suppl 3():34-9. PubMed ID: 19452625
    [No Abstract]   [Full Text] [Related]  

  • 37. Extended-spectrum beta-lactamases: will they be the new 'methicillin-resistant Staphylococcus aureus'?
    Hicks JA; Harris MR; Keoghane SR
    BJU Int; 2008 Jan; 101(2):151-2. PubMed ID: 17760887
    [No Abstract]   [Full Text] [Related]  

  • 38. Evaluation of fosfomycin alone and in combination with ceftriaxone or vancomycin in an experimental model of meningitis caused by two strains of cephalosporin-resistant Streptococcus pneumoniae.
    Ribes S; Taberner F; Domenech A; Cabellos C; Tubau F; Liñares J; Viladrich PF; Gudiol F
    J Antimicrob Chemother; 2006 May; 57(5):931-6. PubMed ID: 16507562
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Concentrations of fosfomycin in serum and lung tissue].
    Adam D; Ritscher R
    MMW Munch Med Wochenschr; 1981 May; 123(21):893-5. PubMed ID: 6789153
    [No Abstract]   [Full Text] [Related]  

  • 40. [Pharmacokinetics of fosfomycin and otitis media].
    Federspil P; Tiesler E; Schätzle W
    Laryngol Rhinol Otol (Stuttg); 1982 Oct; 61(10):591-4. PubMed ID: 7144388
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.